-transparent.png){kind=logo}
We reviewed 251 consecutive adult patients with Hodgkin's disease treated at the Division of Hematology, Policlinico S. Matteo, Pavia, from January 1970 to December 1979, to assess the risk of development of acute leukemia. The median time of follow-up was 48 months (range 6-135). No leukemia occurred in 88 patients treated with radiotherapy or chemotherapy alone. Six acute non-lymphoid leukemias occurred in the group of 163 patients treated with MOPP and radiotherapy (crude rate of leukemia of 7.5 per 1000 person-years at risk). All cases were in clinical remission and off therapy; the latent period from initiation of therapy to onset of leukemia ranged between 30 and 90 months. The actuarial probability of leukemia at five and seven years was 2.9 and 4.7% for the entire group of patients, and 3.8 and 5.8% for the combination therapy group. All leukemias , except one, had a preleukemic phase lasting 1-12 months, with cytopenia and dysplastic marrow. The median survival after leukemia was 4.7 months.
E Brusamolino, and
M Lazzarino, and
L Salvaneschi, and
A Canevari, and
E Morra, and
G Castelli, and
G Pagnucco, and
P Isernia, and
C Bernasconi
April 1978,
The New England journal of medicine,
E Brusamolino, and
M Lazzarino, and
L Salvaneschi, and
A Canevari, and
E Morra, and
G Castelli, and
G Pagnucco, and
P Isernia, and
C Bernasconi
January 1988,
Recenti progressi in medicina,
E Brusamolino, and
M Lazzarino, and
L Salvaneschi, and
A Canevari, and
E Morra, and
G Castelli, and
G Pagnucco, and
P Isernia, and
C Bernasconi
January 1996,
Cancer investigation,
E Brusamolino, and
M Lazzarino, and
L Salvaneschi, and
A Canevari, and
E Morra, and
G Castelli, and
G Pagnucco, and
P Isernia, and
C Bernasconi
September 1998,
Haematologica,
E Brusamolino, and
M Lazzarino, and
L Salvaneschi, and
A Canevari, and
E Morra, and
G Castelli, and
G Pagnucco, and
P Isernia, and
C Bernasconi
November 1984,
Journal of clinical pathology,
E Brusamolino, and
M Lazzarino, and
L Salvaneschi, and
A Canevari, and
E Morra, and
G Castelli, and
G Pagnucco, and
P Isernia, and
C Bernasconi
August 1979,
Haematologica,
E Brusamolino, and
M Lazzarino, and
L Salvaneschi, and
A Canevari, and
E Morra, and
G Castelli, and
G Pagnucco, and
P Isernia, and
C Bernasconi
August 1988,
International journal of cancer,
E Brusamolino, and
M Lazzarino, and
L Salvaneschi, and
A Canevari, and
E Morra, and
G Castelli, and
G Pagnucco, and
P Isernia, and
C Bernasconi
October 1983,
Minerva medica,
E Brusamolino, and
M Lazzarino, and
L Salvaneschi, and
A Canevari, and
E Morra, and
G Castelli, and
G Pagnucco, and
P Isernia, and
C Bernasconi
July 1980,
Blood,
E Brusamolino, and
M Lazzarino, and
L Salvaneschi, and
A Canevari, and
E Morra, and
G Castelli, and
G Pagnucco, and
P Isernia, and
C Bernasconi
October 1994,
Leukemia & lymphoma,
